基于Homogalacturonan丰富的丁基水凝通过NF-κB/NLRP3轴增强了6-生醇通过NF-κB/NLRP3轴的结肠炎缓解作用
Qun Wang1, Zhaomei Wang2, Jun Song3
1Guangdong Provincial Key Laboratory of Functional Food Active Substances, College of Food Sciences, South China Agricultural University, Guangzhou, Guangdong Province 510642, China.
International journal of biological macromolecules
|June 18, 2023
概括
一种新改性pectin水凝装载着纳米脂质载体,将6-醇输送到结肠炎症部位. 这个系统通过向炎症途径和增强药物释放来协同缓解结肠炎.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 胃肠病学 胃肠病学
背景情况:
- 炎症性肠道疾病,特别是结肠炎,是一个重大的治疗挑战.
- 有针对性的药物输送系统对于提高治疗疗效和减少副作用至关重要.
- 6-生 (6G) 具有抗炎性质,但需要有效地输送到结肠.
研究的目的:
- 开发一个结肠炎症部位特定的口服输送系统为6-gingerol (6G).
- 为了研究纳米脂质载体 (NLC) 载荷的homogalacturonan丰富的pectin (MCP4) 水凝 (6G-NLC/MCP4水凝) 的结肠炎缓解作用.
主要方法:
- 制造具有"形"超结构的6G-NLC/MCP4水凝.
- 使用冷扫描电子显微镜进行结构分析.
- 通过在炎症区域的加勒-3相互作用来评估向能力.
- 评估持续药物释放的特征.
- 通过NF-κB/NLRP3信号通路研究协同作用的抗结肠炎效应.
主要成果:
- 6G-NLC/MCP4水凝表现出一种"类似子"的结构,嵌入了6G-NLCs.
- 在MCP4中的homogalacturonan (HG) 域特别准在炎症的结肠区域过度表达的galactin-3.
- 在严重炎症区域实现了6G的持续释放.
- 观察到结肠炎的协同缓解,涉及NF-κB/NLRP3轴的调节.
结论:
- 6G-NLC/MCP4水凝作为有效的结肠炎症部位特定的传递系统为6-gingerol.
- 6-醇向NF-κB通路,并抑制NLRP3的活性.
- MCP4调节了Galectin-3和Rev-Erbα/β,防止了炎症酶激活,从而缓解了协同性结肠炎.
相关概念视频
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
258
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
258
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
202
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
202


